Skip to main content
logo
Indrayani Biotech Limited (BOM:526445)
India flag India · Delayed Price · Currency is INR
8.34
-0.43 (-4.90%)
At close: Oct 23, 2026

Indrayani Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,4641,3781,3021,6621,629615.82
Revenue Growth
14.17%5.84%-21.66%2.02%164.57%190.60%
Gross Profit
410.72437.58474.56672.98590.2201.72
Operating Income
43.7853.2928.94206.58146.7962.17
Net Income
7.543.7-15.5763.6587.3743.93
Earnings Per Share
0.170.08-0.351.402.011.28
EPS Growth
----30.35%57.03%-

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
42.5642.562.88302.52126.9421.8
Total Debt
1,2831,2831,3711,125701.86187.94
Net Cash (Debt)
-1,240-1,240-1,368-822.72-574.92-166.15
Net Cash Growth
------
Net Cash Per Share
-27.24-27.24-30.75-18.07-13.22-4.85

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-316.54-67.42-303.54161.8841.11
Capital Expenditures
--79.05-13.76-164.87-215.28-11.89
Free Cash Flow
-237.49-81.17-468.41-53.429.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
28.05%31.75%36.44%40.49%36.22%32.76%
Operating Margin
2.99%3.87%2.22%12.43%9.01%10.10%
Pretax Margin
0.46%0.22%-4.41%6.60%7.55%7.23%
Profit Margin
0.52%0.27%-1.20%3.83%5.36%7.13%
FCF Margin
-17.23%-6.23%-28.18%-3.28%4.75%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
50.3888.91-35.1822.1423.76
P/FCF Ratio
1.601.39---35.73
PS Ratio
0.260.240.501.351.191.70